Pharmacogenomics (Book)

Pirmohamed, Munir
June 2002
Clinical & Investigative Medicine;Jun2002, Vol. 25 Issue 3, p102
Book Review
Reviews the book 'Pharmacogenomics: Drugs and the Pharmaceutical Sciences Series/113),' edited by Werner Kalow, Urs A. Meyer and Rachel F. Tyndale.


Related Articles

  • Pharmacogenetics (Book). Motulsky, Arno G. // Annals of Internal Medicine;Apr63, Vol. 58 Issue 4, p757 

    Reviews the book 'Pharmacogenetics. Heredity and the Response to Drugs,' by Werner Kalow.

  • How Personalized Medicine Became Genetic, and Racial: Werner Kalow and the Formations of Pharmacogenetics. Jones, David S. // Journal of the History of Medicine & Allied Sciences;Jan2013, Vol. 68 Issue 1, p1 

    Physicians have long puzzled over a well-known phenomenon: different patients respond differently to the same treatment. Although many explanations exist, pharmacogenetics has now captured the medical imagination. While this might seem part of the broader interest in all things genetic, the...

  • Disconnector.  // Utility Week;11/14/2014, p31 

    The article discusses several stories or issues taken in the regular column of the periodical, Disconnector. It mentions no one want to be down a sewer without protective clothing. A resident, Urs Meyer, found a donkey half in and half out of a manhole in Pratteln, Switzerland and rescue it. A...

  • 2006 Award Winners.  // Journal of Psychiatry & Neuroscience;May2006, Vol. 31 Issue 3, p197 

    The article presents the 2006 award winners chosen by the Canadian College of Neuropsychpharmacology. The Heinz Lehmann Award was given to L. Trevor Young while the Innovations in Neuropsychpharmacology Award was given to Rachel Tyndale. Other recipients were Stan Floresco and Sidney Kennedy.

  • Meyer Moves on from Satisloh, Schweiter's Siegrist to Take on CEO Role.  // Vision Monday;11/19/2007, Vol. 21 Issue 13, p10 

    The article announces the resignation of Dr. Urs Meyer as chief executive officer of Satisloh Worldwide effective January 1, 2008 and the appointment of Beat Siegrist as acting Satisloh chief executive officer (CEO) of Schweiter Technologies Group.

  • Variable Drug Metabolism: The Making and Unmaking of Smokers. Vinall, Maria // MD Conference Express;Jun2009, p17 

    The article discusses the report of Dr. Rachel Tyndale chairman of the Canada Research in Pharmacogenetics, Centre for Addiction and Mental Health in the University of Toronto in Ontario, which investigates the relationships between genetics and smoking acquisition and cessation. It states that...

  • Patients fight for small practices. Middlemiss, Prisca // GP: General Practitioner;6/29/2007, p3 

    The article reports on the controversy faced by Primary Care Trust (PCT) regarding the policy of abolishing small and single-handed practices in Great Britain. According to Rachel Tyndall, chief executive officer (CEO) of PCT, small practices often failed to meet the standards of providing...

  • The Ethical Aspect of Pharmacogenomics. Marcy, Joshua // Drug Discovery & Development;Feb2003, Vol. 6 Issue 2, p76 

    Reviews the book 'Pharmacogenomics: Social, Ethical, and Clinical Dimensions,' edited by Mark A. Rothstein.

  • Pharmacogenomics. Kolesar, Jill M. // American Journal of Health-System Pharmacy;8/1/2002, Vol. 59 Issue 15, p1476 

    Reviews the book 'Pharmacogenomics,' edited by Werner Kalow, Urs A. Meyers and Rachel F. Tyndale.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics